Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Haemonetics (HAE) Receivables - Other (2017 - 2022)

Haemonetics (HAE) has 7 years of Receivables - Other data on record, last reported at $6.6 million in Q4 2022.

  • For Q4 2022, Receivables - Other rose 20.0% year-over-year to $6.6 million; the TTM value through Dec 2022 reached $6.6 million, up 20.0%, while the annual FY2022 figure was $5.5 million, 14.58% up from the prior year.
  • Receivables - Other reached $6.6 million in Q4 2022 per HAE's latest filing, down from $7.6 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $10.5 million in Q4 2018 and bottomed at $4.0 million in Q2 2018.
  • Average Receivables - Other over 5 years is $6.1 million, with a median of $5.6 million recorded in 2019.
  • Peak YoY movement for Receivables - Other: surged 147.62% in 2018, then crashed 34.33% in 2021.
  • A 5-year view of Receivables - Other shows it stood at $10.5 million in 2018, then decreased by 23.81% to $8.0 million in 2019, then plummeted by 32.5% to $5.4 million in 2020, then dropped by 18.52% to $4.4 million in 2021, then surged by 50.0% to $6.6 million in 2022.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $6.6 million in Q4 2022, $7.6 million in Q4 2022, and $6.4 million in Q3 2022.